한글목차

세계의 분산형 임상시험 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술 동향, 규제 환경, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 요약
• 개요
• 현재의 시장 시나리오
• 부문 분석
• 지역 분석
• 신기술
• 결론

제2장 시장 개요

• 현재 시장 개요
• 거시경제 요인 분석
• 인구통계학적 요인
• 지정학적 요인
• 미국 관세의 영향
• Porter's Five Forces 분석

제3장 시장 역학

• 시장 역학
• 시장 성장 촉진요인
• 환자 접근성 개선 및 시험의 다양성 요구
• 분산형 임상시험에 대한 바람직한 규제 지원
• 기술 보급과 디지털 인프라
• 시장 성장 억제요인
• 데이터 무결성 및 보안 문제
• 운영 및 물류의 복잡성
• 시장 기회
• AI와 웨어러블 기술 통합
• 의료서비스가 부족한 오지 지역으로의 임상 연구 확대

제4장 규제 현황

• 개요
• 미국
• 유럽
• 아시아태평양

제5장 신규 기술과 개발

• 주요 포인트
• 차세대 디지털 트라이얼 플랫폼 및 통합 생태계 구축
• 웨어러블, 원격 모니터링, 디지털 바이오마커, 디지털 바이오 마커
• 자동화, AI, 예측적 시험 관리
• 디지털 환자 및 연구자 워크플로우 최적화

6장 시장 세분화 분석

• 개요
• 세분화 내역
• 시장 분석 : 연구 설계별
• 주요 포인트
• 중재 시험
• 관찰 시험
• 확장 액세스
• 시장 분석 : 치료 용도별
• 주요 포인트
• 종양
• 심장병
• 기타
• 시장 분석 : 도입 모드별
• 주요 포인트
• 클라우드 기반 DCT 플랫폼
• On-Premise 솔루션
• 시장 분석 : 최종 사용자별
• 주요 포인트
• 제약-바이오 기업
• 임상시험수탁기관(CRO)
• 기타
• 지리적 분류
• 시장 분석 : 지역별
• 주요 포인트
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제7장 경쟁정보

• 주요 포인트
• 경쟁사 분석
• 전략적 접근
• 인수합병(M&A)
• 콜라보레이션

제8장 부록

• 조사방법
• 출처
• 약어
• 기업 소개
• CLARIO
• FORTREA
• ICON PLC
• LABCORP
• MEDABLE INC.
• MEDIDATA
• OBVIO HEALTH USA INC.
• PAREXEL INTERNATIONAL(MA) CORP.
• THERMO FISHER SCIENTIFIC INC.
• VEEVA SYSTEMS INC.

영문목차

The report provides an overview of the global decentralized clinical trials (DCT) market and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and for the forecast period 2025 through 2030.

Report Scope

This report analyzes the trends in the global market for decentralized clinical trials. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period of 2025 through 2030. The market is segmented by study design (interventional trials, observational trials and expanded access), by therapeutic application (oncology, cardiology and other areas) and by deployment mode (cloud-based decentralized clinical trial (DCT) platforms and on-premises solutions). End users include pharmaceutical and biotechnology companies, contract research organizations (CROs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the rest of Europe, China, Japan, India, South Korea and the rest of Asia-Pacific.

The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies. It offers company profiles covering financials, product portfolios and recent developments.

Report Includes

• An overview of the global markets for decentralized clinical trials (DCT)
• An analysis of the global market trends with market revenue data from 2022- 2025, and projected CAGRs through 2030
• Estimates of the size and revenue prospects of the global market, along with a market share analysis by study design, therapeutic application, deployment mode, end user, and region
• Facts and figures pertaining to the market dynamics, technical advances, regulations, impact of macroeconomic factors, and R&D activities
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Company profiles

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Analysis
• Emerging Technologies
• Conclusion

Chapter 2 Market Overview

• Current Market Overview
• Macroeconomic Factors Analysis
• Demographic Factors
• Geopolitical Factors
• Impact of the U.S. Tariffs
• Porter's Five Forces Analysis
• Potential for New Entrants: Moderate
• Bargaining Power of Suppliers: Moderate
• Bargaining Power of Buyers: Moderate to High
• Threat of Substitute Products or Services: Low to Moderate
• Industry Competition: High

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Demand for Improved Patient Access and Trial Diversity
• Favorable Regulatory Support for Decentralized Clinical Trials
• Technological Proliferation and Digital Infrastructure
• Market Restraints
• Data Integrity and Security Concerns
• Operational and Logistical Complexities
• Market Opportunities
• Integration of Artificial Intelligence and Wearable Technologies
• Extending Clinical Research Reach to Underserved and Remote Areas

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologies and Developments

• Key Takeaways
• Next-Generation Digital Trial Platforms and Integrated Ecosystems
• Wearables, Remote Monitoring and Digital Biomarkers
• Automation, AI and Predictive Trial Management
• Digital Patient and Investigator Workflow Optimization

Chapter 6 Market Segmentation Analysis

• Overview
• Segmentation Breakdown
• Market Analysis by Study Design
• Key Takeaways
• Interventional Trials
• Observational Trials
• Expanded Access
• Market Analysis by Therapeutic Application
• Key Takeaways
• Oncology
• Cardiology
• Others
• Market Analysis by Deployment Mode
• Key Takeaways
• Cloud-Based DCT Platforms
• On-Premises Solutions
• Market Analysis by End User
• Key Takeaways
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Other End Users
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Analysis
• Strategic Initiatives
• Mergers and Acquisitions
• Collaborations

Chapter 8 Appendix

• Research Methodology
• Sources
• Abbreviations
• Company Profiles
• CLARIO
• FORTREA
• ICON PLC
• LABCORP
• MEDABLE INC.
• MEDIDATA
• OBVIO HEALTH USA INC.
• PAREXEL INTERNATIONAL (MA) CORP.
• THERMO FISHER SCIENTIFIC INC.
• VEEVA SYSTEMS INC.